Found: 51
Select item for more details and to access through your institution.
A platform trial of neoadjuvant and adjuvant antitumor vaccination alone or in combination with PD-1 antagonist and CD137 agonist antibodies in patients with resectable pancreatic adenocarcinoma.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-39196-9
- By:
- Publication type:
- Article
Postoperative surveillance of pancreatic ductal adenocarcinoma (PDAC) recurrence: practice pattern on standardized imaging and reporting from the society of abdominal radiology disease focus panel on PDAC.
- Published in:
- Abdominal Radiology, 2023, v. 48, n. 1, p. 318, doi. 10.1007/s00261-022-03693-0
- By:
- Publication type:
- Article
Risk of Pancreatic Cancer in the Long-Term Prospective Follow-Up of Familial Pancreatic Cancer Kindreds.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2022, v. 114, n. 12, p. 1681, doi. 10.1093/jnci/djac167
- By:
- Publication type:
- Article
Post-radiation neutrophil-to-lymphocyte ratio is a prognostic marker in patients with localized pancreatic adenocarcinoma treated with anti-PD-1 antibody and stereotactic body radiation therapy.
- Published in:
- Radiation Oncology Journal, 2022, v. 40, n. 2, p. 111, doi. 10.3857/roj.2021.01060
- By:
- Publication type:
- Article
Neoadjuvant Stereotactic Body Radiotherapy After Upfront Chemotherapy Improves Pathologic Outcomes Compared With Chemotherapy Alone for Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma Without Increasing Perioperative Toxicity
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 4, p. 2456, doi. 10.1245/s10434-021-11202-8
- By:
- Publication type:
- Article
High local failure rates despite high margin‐negative resection rates in a cohort of borderline resectable and locally advanced pancreatic cancer patients treated with stereotactic body radiation therapy following multi‐agent chemotherapy.
- Published in:
- Cancer Medicine, 2022, v. 11, n. 7, p. 1659, doi. 10.1002/cam4.4527
- By:
- Publication type:
- Article
Endoplasmic stress‐inducing variants in CPB1 and CPA1 and risk of pancreatic cancer: A case‐control study and meta‐analysis.
- Published in:
- International Journal of Cancer, 2022, v. 150, n. 7, p. 1123, doi. 10.1002/ijc.33883
- By:
- Publication type:
- Article
Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2022, v. 29, n. 1, p. 401, doi. 10.1245/s10434-021-10663-1
- By:
- Publication type:
- Article
ASO Visual Abstract: Anatomic Criteria Determine Resectability in Locally Advanced Pancreatic Cancer.
- Published in:
- 2021
- By:
- Publication type:
- Abstract
Inhibition of focal adhesion kinase enhances antitumor response of radiation therapy in pancreatic cancer through CD8+ T cells.
- Published in:
- Cancer Biology & Medicine, 2021, v. 18, n. 1, p. 206, doi. 10.20892/j.issn.2095-3941.2020.0273
- By:
- Publication type:
- Article
Phase 2 study of vismodegib, a hedgehog inhibitor, combined with gemcitabine and nab-paclitaxel in patients with untreated metastatic pancreatic adenocarcinoma.
- Published in:
- 2020
- By:
- Publication type:
- journal article
A phase 2 study of GVAX colon vaccine with cyclophosphamide and pembrolizumab in patients with mismatch repair proficient advanced colorectal cancer.
- Published in:
- Cancer Medicine, 2020, v. 9, n. 4, p. 1485, doi. 10.1002/cam4.2763
- By:
- Publication type:
- Article
Assessment of iodine uptake by pancreatic cancer following chemotherapy using dual-energy CT.
- Published in:
- Abdominal Radiology, 2018, v. 43, n. 2, p. 445, doi. 10.1007/s00261-017-1338-6
- By:
- Publication type:
- Article
Stereotactic Body Radiation Therapy for Isolated Local Recurrence After Surgical Resection of Pancreatic Ductal Adenocarcinoma Appears to be Safe and Effective.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2018, v. 25, n. 1, p. 280, doi. 10.1245/s10434-017-6134-6
- By:
- Publication type:
- Article
The extracellular matrix and focal adhesion kinase signaling regulate cancer stem cell function in pancreatic ductal adenocarcinoma.
- Published in:
- PLoS ONE, 2017, v. 12, n. 7, p. 1, doi. 10.1371/journal.pone.0180181
- By:
- Publication type:
- Article
Long-term survival benefit of upfront chemotherapy in patients with newly diagnosed borderline resectable pancreatic cancer.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 7, p. 1552, doi. 10.1002/cam4.1104
- By:
- Publication type:
- Article
Using a novel NQO1 bioactivatable drug, beta-lapachone (ARQ761), to enhance chemotherapeutic effects by metabolic modulation in pancreatic cancer.
- Published in:
- Journal of Surgical Oncology, 2017, v. 116, n. 1, p. 83, doi. 10.1002/jso.24624
- By:
- Publication type:
- Article
BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer.
- Published in:
- British Journal of Cancer, 2017, v. 116, n. 8, p. 1021, doi. 10.1038/bjc.2017.40
- By:
- Publication type:
- Article
BRCA2 secondary mutation-mediated resistance to platinum and PARP inhibitor-based therapy in pancreatic cancer.
- Published in:
- 2017
- By:
- Publication type:
- journal article
A phase 1 dose-escalation and expansion study of binimetinib (MEK162), a potent and selective oral MEK1/2 inhibitor.
- Published in:
- 2017
- By:
- Publication type:
- journal article
Phase 1 Study of ABT-751 in Combination With CAPIRI (Capecitabine and Irinotecan) and Bevacizumab in Patients With Advanced Colorectal Cancer.
- Published in:
- Journal of Clinical Pharmacology, 2016, v. 56, n. 8, p. 966, doi. 10.1002/jcph.681
- By:
- Publication type:
- Article
(S016) The Impact of Stereotactic Body Radiation Therapy on Overall Survival in Patients With Locally Advanced Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2016, p. 8
- By:
- Publication type:
- Article
(P013) The Role of CA 19-9 in Patients Receiving Stereotactic Body Radiation Therapy for Locally Advanced Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2016, p. 34
- By:
- Publication type:
- Article
Family history as a marker of platinum sensitivity in pancreatic adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2015, v. 76, n. 3, p. 489, doi. 10.1007/s00280-015-2788-6
- By:
- Publication type:
- Article
The Role of Stereotactic Body Radiation Therapy for Pancreatic Cancer: A Single-Institution Experience.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2015, v. 22, n. 7, p. 2352, doi. 10.1245/s10434-014-4274-5
- By:
- Publication type:
- Article
(P003) Identification of Somatic Mutations Using Fine Needle Aspiration: Correlation With Clinical Outcomes in Patients With Locally Advanced Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2015, v. 29, p. 1
- By:
- Publication type:
- Article
(S021) The Role of Neoadjuvant Stereotactic Body Radiation Therapy in Pancreatic Cancer.
- Published in:
- Oncology (08909091), 2015, v. 29, p. 1
- By:
- Publication type:
- Article
Phase 2 multi-institutional trial evaluating gemcitabine and stereotactic body radiotherapy for patients with locally advanced unresectable pancreatic adenocarcinoma.
- Published in:
- Cancer (0008543X), 2015, v. 121, n. 7, p. 1128, doi. 10.1002/cncr.29161
- By:
- Publication type:
- Article
Development of thyroglobulin antibodies after GVAX immunotherapy is associated with prolonged survival.
- Published in:
- International Journal of Cancer, 2015, v. 136, n. 1, p. 127, doi. 10.1002/ijc.28973
- By:
- Publication type:
- Article
A Safety and Feasibility Study of an Allogeneic Colon Cancer Cell Vaccine Administered with a Granulocyte-Macrophage Colony Stimulating Factor-Producing Bystander Cell Line in Patients with Metastatic Colorectal Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 12, p. 3931, doi. 10.1245/s10434-014-3844-x
- By:
- Publication type:
- Article
The Impact of Postoperative Complications on the Administration of Adjuvant Therapy Following Pancreaticoduodenectomy for Adenocarcinoma.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2014, v. 21, n. 9, p. 2873, doi. 10.1245/s10434-014-3722-6
- By:
- Publication type:
- Article
A phase II study of the gamma secretase inhibitor RO4929097 in patients with previously treated metastatic pancreatic adenocarcinoma.
- Published in:
- Investigational New Drugs, 2014, v. 32, n. 4, p. 739, doi. 10.1007/s10637-014-0083-8
- By:
- Publication type:
- Article
Low Total Lymphocyte Count Is Associated with Poor Survival in Patients with Resected Pancreatic Adenocarcinoma Receiving a GM-CSF Secreting Pancreatic Tumor Vaccine.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2013, v. 20, p. 725, doi. 10.1245/s10434-013-3262-5
- By:
- Publication type:
- Article
Recent progress in pancreatic cancer.
- Published in:
- CA: A Cancer Journal for Clinicians, 2013, v. 63, n. 5, p. 318, doi. 10.3322/caac.21190
- By:
- Publication type:
- Article
A multi-institutional phase 2 study of neoadjuvant gemcitabine and oxaliplatin with radiation therapy in patients with pancreatic cancer.
- Published in:
- Cancer (0008543X), 2013, v. 119, n. 15, p. 2692, doi. 10.1002/cncr.28117
- By:
- Publication type:
- Article
Phase I pharmacokinetic and pharmacodynamic study of cetuximab, irinotecan and sorafenib in advanced colorectal cancer.
- Published in:
- Investigational New Drugs, 2013, v. 31, n. 2, p. 345, doi. 10.1007/s10637-012-9820-z
- By:
- Publication type:
- Article
Phase I study of the safety, tolerability and pharmacokinetics of PHA-848125AC, a dual tropomyosin receptor kinase A and cyclin-dependent kinase inhibitor, in patients with advanced solid malignancies.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 6, p. 2334, doi. 10.1007/s10637-011-9774-6
- By:
- Publication type:
- Article
Integrated preclinical and clinical development of S- trans, trans-farnesylthiosalicylic acid (FTS, Salirasib) in pancreatic cancer.
- Published in:
- Investigational New Drugs, 2012, v. 30, n. 6, p. 2391, doi. 10.1007/s10637-012-9818-6
- By:
- Publication type:
- Article
Integrated preclinical and clinical development of S-trans, trans-farnesylthiosalicylic acid (FTS, Salirasib) in pancreatic cancer.
- Published in:
- 2012
- By:
- Publication type:
- Journal Article
Treating Patients with Colon Cancer Liver Metastasis: A Nationwide Analysis of Therapeutic Decision Making.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2012, v. 19, n. 12, p. 3668, doi. 10.1245/s10434-012-2564-3
- By:
- Publication type:
- Article
A multicenter analysis of GTX chemotherapy in patients with locally advanced and metastatic pancreatic adenocarcinoma.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2012, v. 69, n. 2, p. 415, doi. 10.1007/s00280-011-1704-y
- By:
- Publication type:
- Article
Thymidylate synthase (TYMS) enhancer region genotype-directed phase II trial of oral capecitabine for 2nd line treatment of advanced pancreatic cancer.
- Published in:
- Investigational New Drugs, 2011, v. 29, n. 5, p. 1057, doi. 10.1007/s10637-010-9413-7
- By:
- Publication type:
- Article
Tyrosine 23 Phosphorylation-Dependent Cell-Surface Localization of Annexin A2 Is Required for Invasion and Metastases of Pancreatic Cancer.
- Published in:
- PLoS ONE, 2011, v. 6, n. 4, p. 1, doi. 10.1371/journal.pone.0019390
- By:
- Publication type:
- Article
Adjuvant Chemoradiation Therapy for Adenocarcinoma of the Distal Pancreas.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 12, p. 3112, doi. 10.1245/s10434-010-1200-3
- By:
- Publication type:
- Article
Phase I Trial of Oxaliplatin, Infusional 5-Fluorouracil, and Leucovorin (FOLFOX4) With Erlotinib and Bevacizumab in Colorectal Cancer.
- Published in:
- Clinical Colorectal Cancer, 2010, v. 9, n. 5, p. 297, doi. 10.3816/CCC.2010.n.043
- By:
- Publication type:
- Article
Adjuvant Chemoradiation for Pancreatic Adenocarcinoma: The Johns Hopkins Hospital—Mayo Clinic Collaborative Study.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2010, v. 17, n. 4, p. 981, doi. 10.1245/s10434-009-0743-7
- By:
- Publication type:
- Article
Prognostic Significance of Tumorigenic Cells With Mesenchymal Features in Pancreatic Adenocarcinoma.
- Published in:
- JNCI: Journal of the National Cancer Institute, 2010, v. 102, n. 5, p. 340, doi. 10.1093/jnci/djp535
- By:
- Publication type:
- Article
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas.
- Published in:
- Investigational New Drugs, 2008, v. 26, n. 4, p. 369, doi. 10.1007/s10637-008-9123-6
- By:
- Publication type:
- Article
Evaluating the Impact of a Single-Day Multidisciplinary Clinic on the Management of Pancreatic Cancer.
- Published in:
- Annals of Surgical Oncology: An Oncology Journal for Surgeons, 2008, v. 15, n. 8, p. 2081, doi. 10.1245/s10434-008-9929-7
- By:
- Publication type:
- Article
Phase I and pharmacokinetic study of UCN-01 in combination with irinotecan in patients with solid tumors.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2008, v. 61, n. 3, p. 423, doi. 10.1007/s00280-007-0485-9
- By:
- Publication type:
- Article